IL-23R rs11209026 polymorphism modulates IL-17A expression in patients with rheumatoid arthritis

Genes and Immunity

Volumn 13, Issue 3, 2012, Pages 282-287

  Hazlett, J ^a   Stamp, L K ^b   Merriman, T ^a   Highton, J ^a   Hessian, P A ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

IL 17A; IL 23R; rheumatoid arthritis

Indexed keywords

ARGININE; GLUTAMINE; INTERLEUKIN 12; INTERLEUKIN 12P40; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 21; INTERLEUKIN 22; INTERLEUKIN 23 RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ALLELE; AMINO ACID SUBSTITUTION; ARTICLE; BLOOD LEVEL; CYTOKINE PRODUCTION; DNA POLYMORPHISM; FEMALE; GENE EXPRESSION; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS;

ADULT; AGED; AGED, 80 AND OVER; ARTHRITIS, RHEUMATOID; C-REACTIVE PROTEIN; FEMALE; GENOTYPE; HUMANS; INTERLEUKIN-12; INTERLEUKIN-17; INTERLEUKINS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, INTERLEUKIN; YOUNG ADULT;

EID: 84859887556     PISSN: 14664879     EISSN: 14765470     Source Type: Journal    
DOI: 10.1038/gene.2011.80     Document Type: Article

References (42)

1. Ferber I, Brocke S, Taylor-Edwards C, Ridgway W, Dinisco C, Steinman L et al. Mice with a disrupted IFN-gamma gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE). J Immunol 1996; 156: 5-7.
2. Jones L, Rizzo L, Agarwal R, Tarrant T, Chan C, Wiggert B et al. IFN-gamma-deficient mice develop experimental autoimmune uveitis in the context of a deviant effector response. J Immunol 1997; 158: 5997-6005. (Pubitemid 127484009)
3. Matthys P, Vermeire K, Mitera T, Heremans H, Huang S, Billiau A. Anti-IL-12 antibody prevents the development and progression of collagen-induced arthritis in IFN-gamma receptor-deficient mice. Eur J Immunol 1998; 28: 2143-2151. (Pubitemid 28321298)
4. von Delwig A, Locke J, Robinson J, Ng W. Response of Th17 cells to a citrullinated arthritogenic aggrecan peptide in patients with rheumatoid arthritis. Arthritis Rheum 2010; 62: 143-149.
5. Genovese M, Van den Bosch F, Roberson S, Bojin S, Biagini I, Ryan P et al. LY2439821, a humanized anti-IL-17 monoclonal antibody, in the treatment of patients with rheumatoid arthritis. Arthritis Rheum 2010; 62: 929-939.
6. Stamp LK, Easson A, Pettersson L, Highton J, Hessian PA. Monocyte derived IL-23 is an important determinant of synovial IL-17A expression in rheumatoid arthritis. J Rheumatol 2009; 36: 2403-2408.
7. Muller-Berghaus J, Kern K, Paschen A, Nguyen X, Kluter H, Morahan G et al. Deficient IL-12p70 secretion by dendritic cells based on IL12B promoter genotype. Genes Immun 2004; 5: 421-424.
8. Windsor L, Morahan G, Huang D, McCann V, Jones T, James I et al. Alleles of the IL12B 30UTR associate with late onset of type 1 diabetes. Human Immunol 2004; 65: 1432-1436. (Pubitemid 39643223)
9. van Veen T, Crusius J, Schrijver H, Bouma G, Killestein J, van Winsen L et al. Interleukin-12p40 genotype plays a role in the susceptibility to multiple sclerosis. Ann Neurol 2001; 50: 275.
10. Nair R, Ruether A, Stuart P, Jenisch S, Tejasvi T, Hiremagalore R et al. Polymorphisms of the IL12B and IL23R genes are associated with psoriasis. J Invest Dermatol 2008; 128: 1653-1661. (Pubitemid 351847381)
11. Duerr R, Taylor K, Brant S, Rioux J, Silverberg M, Daly M et al. A Genome-Wide Association Study identifies IL23R as an inflammatory bowel disease gene. Science 2006; 314: 1461-1463. (Pubitemid 44871953)
12. Nunez C, Dema B, Cenit M, Polanco I, Maluenda C, Arroyo R et al. IL23R: a susceptibility locus for celiac disease and multiple sclerosis? Genes Immun 2008; 9: 289-293. (Pubitemid 351791483)
13. Capon F, Di Meglio P, Szaub J, Prescott N, Dunster C, Baumber L et al. Sequence variants in the genes for the interleukin-23 receptor (IL23R) and its ligand (IL12B) confer protection against psoriasis. Hum Genet 2007; 122: 201-206. (Pubitemid 47241785)
14. Hollis-Moffatt J, Merriman M, Rodger R, Rowley K, Chapman P, Dalbeth N et al. Evidence for association of an interleukin 23 receptor variant independent of the R381Q variant with rheumatoid arthritis. Ann Rheum Dis 2009; 68: 1340-1344.
15. Sarin R, Wu X, Abraham C. Inflammatory disease protective R381Q IL23 receptor polymorphism results in decreased primary CD4+ and CD8+ human T-cell functional responses. PNAS 2011; 108: 9560-9565.
16. Lubberts E, van den Bersselaar L, Oppers-Walgreen B, Schwarzenberger P, Coenen-de Roo C, Kolls J et al. IL-17 promotes bone erosion in murine collagen-induced arthritis through loss of the receptor activator of NF-κB ligand/osteoprotegerin balance. J Immunol 2003; 170: 2655-2662. (Pubitemid 36245658)
17. Maiti A, Kim-Howard X, Viswanathan P, Guillén L, Rojas-Villarraga A, Deshmukh H et al. Confirmation of an association between rs6822844 at the IL2-IL21 region and multiple autoimmune diseases: evidence of a general susceptibility locus. Arthritis Rheum 2010; 62: 323-329.
18. Hollis-Moffatt J, Chen-Xu M, Topless R, Dalbeth N, Gow P, Harrison A et al. Only one independent genetic association with rheumatoid arthritis within the KIAA1109-TENR-IL2-IL21 locus in Caucasian sample sets: confirmation of association of rs6822844 with rheumatoid arthritis at a genome-wide level of significance. Arthritis Res Ther 2010; 12: R116.
19. 17 cells: shifting the focus to function. Nature Immunol 2010; 11: 471-476.
20. Marder W, Khalatbari S, Myles J, Hench R, Yalavarthi S, Lustig S et al. Interleukin 17 as a novel predictor of vascular function in rheumatoid arthritis. Ann Rheum Dis 2011; 70: 1550-1555.
21. Wallis S, Cooney L, Endres J, Lee M, Ryu J, Somers E et al. A polymorphism in the interleukin-4 receptor affects the ability of interleukin-4 to regulate Th17 cells; a possible immunoregulatory mechanism for genetic control of the severity of rheumatoid arthritis. Arthritis Res Ther 2011; 13: R15.
22. Koenders M, Marijnisses R, Devesa I, Lubberts E, Joosten L, Roth J et al. Tumor necrosis factor-interleukin-17 interplay induces S100A8, interleukin-1b, and matrix metalloproteinases, and drives irreversible cartilage destruction in murine arthritis. Arthitis Rheum 2011; 63: 2329-2339.
23. Di Meglio P, Di Cesare A, Laggner U, Chu C, Napolitano L, Villanova F et al. The IL23R R381Q gene variant protects against immune-mediated diseases by impairing IL-23-induced Th17 effector response in humans. PLoS ONE 2011; 6: e17160.
24. Mus A, Cornelissen F, Asmawidjaja P, van Hamburg J, Boon L, Hendriks R et al. Interleukin-23 promotes Th17 differentiation by inhibiting T-bet and FoxP3 and is required for elevation of interleukin-22, but not interleukin-21, in autoimmune experimental arthritis. Arthritis Rheum 2010; 62: 1043-1050.
25. Volpe E, Touzot M, Servant N, Marloie-Provost M-A, Hupe P. Multiparametric analysis of cytokine-driven human Th17 differentiation reveals differential regulation of IL-17 and IL-22 production. Immunobiol 2009; 114: 3610-3614.
26. Zenewicz L, Flavell R. IL-22 and inflammation: leukin' through a glass onion. Eur J Immunol 2008; 38: 3265-3268.
27. Colonna M. Interleukin-22 producing natural killer cells and lymphoid tissue inducer-like cells in mucosal immunity. Immunity 2009; 31: 15-23.
28. Takatori H, Kanno Y, Watford W, Tato C, Weiss G, Ivanov I et al. Lymphoid tissue induced-like cells are an innate source of IL-17 and IL-22. J Exp Med 2009; 206: 35-41.
29. Danis V, Franic G, Rathjen D, Laurent R, Brooks P. Circulating cytokine levels in patients with rheumatoid arthritis: results of a double blind trial with sulphasalazine. Ann Rheum Dis 1992; 51: 946-950.
30. Kim H-R, Kim H-S, Park M-K, Cho M-L, Lee S-H, Kim H-Y. The clinical role of IL-23p19 in patients with rheumatoid arthritis. Scand J Rheumatol 2007; 36: 259-264. (Pubitemid 47346915)
31. Melis L, Vandooren B, Kruithof E, Jacques P, De Vos M, Mielants H et al. Systemic levels of IL-23 are strongly associated with disease activity in rheumatoid arthritis but not spondyloarthritis. Ann Rheum Dis 2010; 69: 618-623.
32. Eastgate J, Symons J, Wood N, Grinlinton F, di Giovine F, Duff G. Correlation of plasma interleukin-1 levels with disease activity in rheumatoid arthritis. Lancet 1988; 2: 706-709.
33. Jungel A, Distler J, Kurowska-Storlarska M, Seemayer C, Siebl R, Forster A et al. Expression of interleukin-21 receptor, but not interleukin-21, in synovial fibroblasts and synovial macrophages of patients with rheumatoid arthritis. Arthritis Rheum 2004; 50: 1468-1476. (Pubitemid 38608068)
34. Andersson A, Feldmann M, Brennan F. Neutralizing IL-21 and IL-15 inhibits proinflammatory cytokine production in rheumatoid arthritis. Scan J Immunol 2008; 68: 103-111. (Pubitemid 351798402)
35. Rasmussen T, Andersen T, Hvid M, Hetland M, Horslev-Petersen K, Stengaard-Pedersen K et al. Increased interleukin 21 (IL-21) and IL-23 are associated with increased disease activity and with radiological status in patients with early rheumatoid arthritis. J Rheumatol 2010; 37: 2914-2920.
36. Prabhala R, Pelluru D, Fulciniti M, Prabhala H, Nanjappa P, Song S et al. Elevated IL-17 produced byTH17 cells promotes myeloma cell growth and inhibits immune function in multiple myeloma. Blood 2010; 115: 5385-5392.
37. Li J, Shen W, Kong K, Liu Z. Interleukin-21 induces T cells activation and pro-inflammatory cytokine secretion in rheumatoid arthritis. Scan J Immunol 2006; 64: 515-522. (Pubitemid 44536336)
38. Niu X, He D, Zhang T, Li N, Zhang J, Dong C et al. IL-21 regulates Th17 cells in rheumatoid arthritis. Human Immunol 2010; 71: 334-341.
39. Geboes L, Dumoutier L, Kelchtermans H, Schurgers E, Miltera T, Renauld J et al. Proinflammatory role of the Th17 cytokine interleukin-22 in collagen induced arthritis in C57BL/6 mice. Arthritis Rheum 2009; 60: 390-395.
40. Ikeuchi H, Kuroiwa T, Hiramatsu N, Kaneko Y, Hiromura K, Ueki K et al. Expression of interelukin-22 in rheumatoid arthritis. Arthritis Rheum 2005; 52: 1037-1046.
41. Leipe J, Schramm M, Grunke M, Baeuerle M, Dechant C, Nigg A et al. Interleukin 22 serum levels are associated with radiographic progression in rheumatoid arthritis. Ann Rheum Dis 2011; 70: 1453-1457.
42. Arnett F, Edworthy SM, Bloch D, McShane D, Fries J, Cooper N et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-324. (Pubitemid 18091653)